Lightnews — Scholar-powered news

Maria Carrillo @mariacarrilloalz.bsky.social · 7d

ISTAART is monitoring the potential impact of the government shutdown on researchers & the dementia care community where funds & staffing capacity are critical.

Thanks to @alzassociation advocacy, NIH requested $187M increase in FY27. Bipartisan momentum in Congress is strong!

1

Maria Carrillo @mariacarrilloalz.bsky.social · 20d

Proud to share the Alzheimer’s Association invested $112.2M in research activities over the last year — our largest single-year commitment. From gene therapy to #BrainHealth to risk reduction to AI, we’re funding bold boundary-pushing ideas. alz.org/research

#ENDALZ

Alzheimer's & Dementia Research | Alzheimer's Association

Alzheimer's and dementia research – find the latest update on research funding, grants, clinical trials and global research news.

alz.org

2 4

Maria Carrillo @mariacarrilloalz.bsky.social · Jul 29

#AAIC2025 following USPointer recipe with a morning fun run!

4

Maria Carrillo @mariacarrilloalz.bsky.social · Jul 29

Today’s news from #AAIC25 marks a moment so many of us in the Alzheimer’s and dementia scientific community have long hoped for. We can now say with confidence that lifestyle interventions can protect brain health in diverse communities in the U.S.

Alzheimer's Association @alzassociation.bsky.social · Jul 28

📣Today is a turning point in what we know about brain health.

The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S.
#AAIC25 alz.org/USPOINTERresults

6

Reposted by Maria Carrillo

Alzheimer's Association @alzassociation.bsky.social · Jul 28

📣Today is a turning point in what we know about brain health.

The results from the U.S. POINTER trial provide the rigorous data needed to say with confidence that healthy behaviors can meaningfully protect brain health across diverse populations in the U.S.
#AAIC25 alz.org/USPOINTERresults

2 15 25

Maria Carrillo @mariacarrilloalz.bsky.social · Jun 18

“This is just the beginning,” @BillGates.bsky.social wrote in a new blog post. He’s right — Alzheimer’s and dementia research has more momentum than ever before, but now we need to go faster, earlier and bolder. That’s what @ALZAssocation’s Part the Cloud is all about.

Alzheimer's Association @alzassociation.bsky.social · Jun 18

In a new blog post, @billgates.bsky.social shares his hope for—and commitment to—the fight to #ENDALZ, highlighting his support for the Association’s Part the Cloud initiative, which funds high-risk, high-reward clinical trials aimed at accelerating scientific breakthroughs. gatesnot.es/4edi98q

gatesnot.es

3

Maria Carrillo @mariacarrilloalz.bsky.social · Jun 13

Congratulations to the recipients of the @alzassociation Part the Cloud Gene Targeting Challenge. This funding program is focused on gene editing, with the aim of developing potential therapies that change the expression of a gene at some level. bit.ly/4l8yEVx

Alzheimer's Association Part the Cloud Grants $5 Million to Develop Gene Targeting Treatments

Through the Alzheimer's Association, the Part the Cloud grants support development of innovative gene targeting treatments for Alzheimer's and dementia.

bit.ly

2

Maria Carrillo @mariacarrilloalz.bsky.social · May 16

The myths and fabrications persistently shared by the Health and Human Services Secretary aren’t just disappointing – they’re dangerous. See below for the facts and for our full statement in response to the Secretary’s comments.

Alzheimer's Association @alzassociation.bsky.social · May 15

❌ FALSE: “For 20 years…we were directing Alzheimer’s research to one hypothesis. And any other hypotheses were shut down.” - Sec. Kennedy

Over the last decade, less than 14% of new National Institutes of Health (NIH) Alzheimer’s projects focused on amyloid beta as the therapeutic target. 🧵(1/4)

1 10 17

Reposted by Maria Carrillo

Prof Malú Gámez Tansey @malutansey.bsky.social · Apr 14

It was a privilege to deliver one of the keynotes at today’s #CNDSymposium Day2 @iusm-medneuro.bsky.social alongside @elizabethhead.bsky.social @mariacarrilloalz.bsky.social. Congrats to @wilcocklab.bsky.social for the amazing 2 days of science 🤓💪🏼

4 22

Maria Carrillo @mariacarrilloalz.bsky.social · Mar 25

@alzassociation.bsky.social CEO Dr Joanne Pike and the World Dementia Council rising chair is closing a fantastic day of discussions to accelerate innovation and deliver change! #ENDALZ

3

Reposted by Maria Carrillo

Eric Siemers @esiemers.bsky.social · Mar 22

jamanetwork.com/journals/jam...

The Bad Medicine of Doctored

This Viewpoint discusses a recent book that alleges scientific misconduct in Alzheimer disease (AD) research; summarizes actual progress made in the field; suggests that the book contributes to a narr...

jamanetwork.com

1 3

Reposted by Maria Carrillo

Laura Stankeviciute, PhD @laura-sofia-s.bsky.social · Mar 5

📣 Join the "The Basics: Glymphatic System – A Focus on the Role of Sleep" @istaart.bsky.social webinar to learn the fundamental mechanisms of the glymphatic system and the critical role of #sleep in its function. 🧠🧼💤

📆 Register alz-org.zoom.us/webinar/regi...

@claireandre.bsky.social #EndAlz

3 6

Maria Carrillo @mariacarrilloalz.bsky.social · Mar 6

Observations from today’s confirmation hearing for the director of the NIH: 1. bipartisan support for addressing dementia was on full display & 2. harmful myths about Alzheimer’s research continue to persist and that needs to stop. Our full statement: bit.ly/4bql5Nv

Bipartisan Support for Alzheimer’s and Dementia Research During Senate HELP Committee

Read the Alzheimer's Association statement on the Senate HELP Committee hearing for the National Institutes of Health (NIH) director nominee.

bit.ly

1 3

Maria Carrillo @mariacarrilloalz.bsky.social · Mar 4

So honored to be a part of this first symposium @IU @wilcocklab.bsky.social @malutansey.bsky.social to #ENDALZ

Dr. Donna Wilcock @wilcocklab.bsky.social · Mar 4

We encourage everyone who can to join us for the first annual Center for Neurodegenerative Disorders Symposium. Sunday April 13th for our community event and / or Monday April 14th for our scientific event. This is a free event and we have a virtual option! Scan the QR code to register!

1 6

Reposted by Maria Carrillo

Yakeel T. Quiroz, PhD @ytquiroz.bsky.social · Jan 12

Join us this week in San Juan #PuertoRico for Human Amyloid Imaging Conference #HAI2025 😊 Excited to participate in a panel discussion on disparities in neuroimaging & AD research, organized by the ISTAART Neuroimaging PIA and Diversity & Disparities PIA (Prof Interest Area)🤩

Love Languages GIF

ALT: Love Languages GIF

media.tenor.com

1 11

Reposted by Maria Carrillo

Melissa E. Murray @drneurochic.bsky.social · Jan 8

What an incredible time period to be working on updated appropriate use criteria for amyloid and tau PET! Awesome group to work with...I learned so much🧠

alz-journals.onlinelibrary.wiley.com/doi/10.1002/...

@alzassociation.bsky.social @snm-mi.bsky.social

Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup

INTRODUCTION The Alzheimer's Association and the Society of Nuclear Medicine and Molecular Imaging convened a multidisciplinary workgroup to update appropriate use criteria (AUC) for amyloid positro.....

alz-journals.onlinelibrary.wiley.com

2 7 24

Reposted by Maria Carrillo

Oz Ismail @ozyismail.bsky.social · Jan 8

🚨 ISTAART Voices is back! 🎉

Join us as we chat with scientists about their groundbreaking work from the Alzheimer’s & Dementia journal family.

Tune in on your favorite podcast platforms, or visit alz.org/ISTAARTpodcasts! 🎧

1 3 5